Impact of acquired broad-spectrum β-lactamases on susceptibility to oral penems/carbapenems (tebipenem, sulopenem, and faropenem) alone or in combination with avibactam and taniborbactam β-lactamase inhibitors in Escherichia coliChristophe Le Terrier & Patrice Nordmann & Maxime Bouvier & Laurent Poirel2023PDF317 KBEN
Sasanlimab Plus BCG in BCG-naive, High-risk Non-muscle Invasive Bladder CancerNeal D. Shore & Thomas B. Powles & Jens Bedke & Matthew D. Galsky & Joan Palou Redorta & Ja Hyeon Ku & Michal Kretkowski & Evanguelos Xylinas & Boris Alekseev & Dingwei Ye & Félix Guerrero-Ramos & Alberto Briganti & Girish S. Kulkarni & Julia Brinkmann...2025PDF4.1 MBEN
Author CorrectionNeal D. Shore & Thomas B. Powles & Jens Bedke & Matthew D. Galsky & Joan Palou Redorta & Ja Hyeon Ku & Michal Kretkowski & Evanguelos Xylinas & Boris Alekseev & Dingwei Ye & Félix Guerrero-Ramos & Alberto Briganti & Girish S. Kulkarni & Julia Brinkmann...2025PDF461 KBEN